Atomic AI, USA — RNA Structure Intelligence Platform for Drug Discovery

Mission

Accelerate the discovery and optimization of RNA-centric medicines — including RNA-targeted small molecules and RNA-based therapeutics — by combining machine learning and structural biology to predict 3D RNA structures and unlock previously undruggable targets.

Context

Many disease-relevant RNA structures remain “undruggable” because predicting their 3D shapes and functional properties has been historically slow, costly, and limited in scope. Without high-precision structural insights, biopharma R&D teams face high failure rates and long timelines in drug discovery. Enterprises pursuing RNA medicines need predictive, scalable computational platforms that reduce experimental burden and reveal new therapeutic opportunities.

AI Asset

Atomic AI delivers a foundation platform for RNA structure prediction and therapeutic design that:

• Predicts RNA 3D structure with high precision using deep learning models

• Integrates large-scale chemical mapping data and in-house experimental assays

• Enables the design of RNA-targeted molecules and RNA modalities

• Accelerates discovery workflows for RNA-based and RNA-targeted drug modalities

Proof 

• Raised $35M+ in Series A financing to advance its RNA structure platform, backed by Playground Global, 8VC, Greylock, and other strategic investors.

• Platform research has been featured in Science, highlighting scientific credibility and innovation.

• Created the ATOM-1 foundation model, trained on chemical mapping data to predict RNA structure and function more accurately than competing tools.

These signals reflect enterprise-grade adoption, investment backing, and real scientific traction — not laboratory pilot experiments.

Outcomes

• Faster discovery cycles for RNA-targeted and RNA-based therapeutics

• Higher probability of success in early drug design decisions

• Reduced experimental cost and uncertainty through in-silico predictions

• Access to previously inaccessible therapeutic targets in oncology, rare diseases, and beyond

Website

https://www.atomic.ai/

Reference Videos 

1️⃣ How AI and RNA Tech is Transforming Drug Discovery
https://www.youtube.com/watch?v=Ai80EsztnhE
An AI + RNA drug discovery discussion featuring Raphael Townshend, Founder & CEO of Atomic AI, about how AI transforms RNA-centric therapeutic discovery.

2️⃣ Revolutionizing RNA Drug Discovery with AI and Structural Biology
https://www.youtube.com/watch?v=TOjpGPsBtiY
Explores the fusion of machine learning and structural biology in RNA drug discovery — core to Atomic AI’s mission.

3️⃣ AI’s Role in Accelerating Drug Development and Clinical Trials
https://www.youtube.com/watch?v=OXJjpImlgqY
Raphael Townshend (Atomic AI) joins a broader discussion on how AI speeds up drug discovery and development workflows.

4️⃣ AI Meets RNA: Atomic AI’s Drug Discovery Strategy
https://www.youtube.com/watch?v=QfCzPw0V3xU
A podcast episode featuring Atomic AI insights on how generative AI and RNA drug discovery are reshaping the field.